Cargando…

The clinical features, prognostic significance, and immune heterogeneity of CD37 in diffuse gliomas

Diffuse glioma is the most prevalent and malignant brain tumor. The function and significance of CD37 in diffuse gliomas remain largely unknown. Here, we showed CD37 was abnormally expressed in diverse cancers, especially glioma by pan-cancer differential expression analysis. In addition, we found C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Xuejun, Zhou, Quanwei, Zhu, Hecheng, Liu, Weidong, Xu, Hongjuan, Yin, Wen, Zhao, Ming, Jiang, Xingjun, Ren, Caiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564053/ https://www.ncbi.nlm.nih.gov/pubmed/34755091 http://dx.doi.org/10.1016/j.isci.2021.103249

Ejemplares similares

Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis
por: Zhou, Quanwei, et al.
Publicado: (2020)

Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma
por: Zhou, Quanwei, et al.
Publicado: (2021)

Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma
por: Cao, Yudong, et al.
Publicado: (2022)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma
por: Yin, Wen, et al.
Publicado: (2021)

Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma
por: Wu, Zhaoping, et al.
Publicado: (2023)

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
por: Jiang, Zhipeng, et al.
Publicado: (2021)

A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
por: Zhou, Yi, et al.
Publicado: (2023)

FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies
por: Shen, Wenyue, et al.
Publicado: (2022)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
por: Yin, Wen, et al.
Publicado: (2020)

Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients
por: Tan, Jun, et al.
Publicado: (2021)

TBL1X and Flot2 form a positive feedback loop to promote metastasis in nasopharyngeal carcinoma
por: Xu, Hongjuan, et al.
Publicado: (2022)

Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma
por: Cao, Yudong, et al.
Publicado: (2022)

The prognostic significance of p16 expression pattern in diffuse gliomas
por: Park, Jin Woo, et al.
Publicado: (2021)

Effects of three-dimensional collagen scaffolds on the expression profiles and biological functions of glioma cells
por: Jia, Wei, et al.
Publicado: (2018)

Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
por: Huo, Yu-Jia, et al.
Publicado: (2022)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas
por: Zhao, Zheng, et al.
Publicado: (2020)

Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases
por: Shi, Ning, et al.
Publicado: (2022)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021)

Crucial roles of different RNA-binding hnRNP proteins in Stem Cells
por: Xie, Wen, et al.
Publicado: (2021)

When stem cells meet COVID-19: recent advances, challenges and future perspectives
por: Li, Shasha, et al.
Publicado: (2022)

SYK Is Associated With Malignant Phenotype and Immune Checkpoints in Diffuse Glioma
por: Zhou, Quanwei, et al.
Publicado: (2022)

Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation
por: Wang, Qing, et al.
Publicado: (2019)

Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse Gliomas
por: Mirchia, Kanish, et al.
Publicado: (2020)

Systematic Analysis of 4-gene Prognostic Signature in Patients with Diffuse Gliomas Based on Gene Expression Profiles
por: Huang, Chunhai, et al.
Publicado: (2021)

LncRNAs and their RBPs: How to influence the fate of stem cells?
por: Zhao, Cong, et al.
Publicado: (2022)

Prognostic significance of ARL9 and its methylation in low-grade glioma
por: Tan, Yutang, et al.
Publicado: (2020)

Construction and experimental validation of a signature for predicting prognosis and immune infiltration analysis of glioma based on disulfidptosis-related lncRNAs
por: Guo, Youwei, et al.
Publicado: (2023)

GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis
por: Liang, Kairong, et al.
Publicado: (2023)

A B7-CD28 Family-Based Signature Demonstrates Significantly Different Prognosis and Immunological Characteristics in Diffuse Gliomas
por: Deng, Xiangyang, et al.
Publicado: (2022)

Novel CD37, Humanized CD37 and Bi-Specific Humanized CD37-CD19 CAR-T Cells Specifically Target Lymphoma
por: Golubovskaya, Vita, et al.
Publicado: (2021)

The Significance of MGMT Promoter Methylation Status in Diffuse Glioma
por: Jovanović, Nikola, et al.
Publicado: (2022)

Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma
por: Bugiani, Marianna, et al.
Publicado: (2017)

Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers
por: Zhu, Wei, et al.
Publicado: (2019)

Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas
por: Zeng, Wenxin, et al.
Publicado: (2020)

Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma
por: Yuan, Yongliang, et al.
Publicado: (2019)

Differential and Prognostic Significance of HOXB7 in Gliomas
por: Zhou, Xingang, et al.
Publicado: (2021)

Educational Case: Histologic and Molecular Features of Diffuse Gliomas
por: Zhang, Sarah, et al.
Publicado: (2020)

Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2022)

Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma
por: Kang, Yuanbo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oj3blk77dp5jr1f9n1f2uc2tl8